Menlo Therapeutics (“MNLO”) I.P.O. Losses
In January 2018, Menlo Therapeutics went public issuing over 8,000,000 shares of common stock at a public offering price of $17.00 raising over 125 million dollars. NASDAQ lists Menlo’s stock under the ticker symbol “MNLO.”
Jefferies LLC, Piper Jaffray & Co. and Guggenheim Securities served as the lead underwriters. Menlo’s stock price, MNLO, initially skyrocketed. However, the stock recently plummeted after poor test results costing investors millions of dollars.
Contact Our Firm if You’ve Invested in Menlo Therapeutics (“MNLO”)
Securities Arbitration Lawyers Blog












Silver Law Group is currently investigating Boston, MA and New York, NY based broker James S. Polese regarding complaints pertaining to failure to provide due diligence to investor clients,
Group is currently investigating Melville, NY based broker Joseph Francis Valdini regarding complaints pertaining to failure to provide due diligence to investor clients and placing unauthorized trades with subsequent margin call sellouts that caused major financial damages to investors.
Silver Law Group is currently investigating Cleveland, Ohio based broker Joseph Daniel Krueger II regarding complaints pertaining to engaging in outside securities transactions by issuing and